May 12, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: | Dillon Hagius |
Irene Paik |
Christie Wong |
Vanessa Robertson |
Re: | Vera Therapeutics, Inc. |
Registration Statement on Form S-1 |
Registration No. 333-255492 |
Acceleration Request |
Requested Date: May 13, 2021 |
Requested Time: 4:30 PM, Eastern Time |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the Act), Jefferies LLC, Cowen and Company, LLC and Evercore Group L.L.C., as representatives of the several underwriters, hereby join Vera Therapeutics, Inc. in requesting that the Securities and Exchange Commission (the Commission) take appropriate action to cause the Registration Statement on Form S-1, as amended (File No. 333-255492) (the Registration Statement) to become effective on May 13, 2021, at 4:30 PM, Eastern Time, or as soon as practicable thereafter.
Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.
[Signature Page Follows]
Very truly yours, | ||
Jefferies LLC | ||
By: | /s/ Michael Brinkman |
Name: | Michael Brinkman | |
Title: | Managing Director | |
Cowen and Company, LLC | ||
By: | /s/ Bill Follis |
Name: | Bill Follis | |
Title: | Managing Director | |
Evercore Group L.L.C. | ||
By: | /s/ Ed Baxter |
Name: | Ed Baxter | |
Title: | Senior Managing Director |
cc: | Jonathan Wolter, Vera Therapeutics, Inc. |
Heidi Mayon, Goodwin Procter LLP |
Jesse Nevarez, Goodwin Procter LLP |
Jodie Bourdet, Cooley LLP |
Carlton Fleming, Cooley LLP |
[Signature Page to Acceleration Request]